Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT05698316
Eligibility Criteria:
Inclusion Criteria:
Each dataset per patient should have one eye as the study eye with:
* Intermediate AMD with no atrophy and no subretinal drusenoid deposits
* Intermediate AMD with no atrophy with subretinal drusenoid deposits
* Intermediate AMD with early atrophy (iRORA) with no Subretinal drusenoid deposits
* Intermediate AMD with early atrophy (iRORA) with Subretinal drusenoid deposits
* Intermediate AMD with evidence of cRORA
Non-study eye images will not be exported but information about the status of the macula should be added using the following options:
* Established Geographic Atrophy (cRORA)
* Exudative AMD (presence of MNV)
* Early AMD
* Healthy macula
Exclusion Criteria:
* Both eyes have exudative AMD or geographic atrophy at baseline.
* Co-existent ocular disease: Any other ocular condition that, in the investigator's opinion, might affect or alter visual acuity during the study.
* Any patient who has opted out of their information being used for research nationally or locally at any Member Site.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05698316
Study Brief:
Protocol Section:
NCT05698316